4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-24-008641
CHIEF TECHNOLOGY OFFICER sold 40,000 shares at an average $6.74 ($269,600)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming CHIEF TECHNOLOGY OFFICER | 2024-03-18 | Sale 10b5-1 | −20,000 | $6.77 | $135,400 | 6,030,402 | D |
| Yan Ming CHIEF TECHNOLOGY OFFICER | 2024-03-19 | Sale 10b5-1 | −20,000 | $6.71 | $134,200 | 6,010,402 | D |
| Open-market sales · 40,000 sh · avg $6.74 · $269,600 | |||||||
Loading xslF345X05/form4-03192024_100347.xml…